1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
69E66EFA50252F48D00258A54003CB800
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-pioneering-patient-centric-growth-navigating-success-with-journey-maps-co-creation?opendocument
18
19opendocument
2034.239.151.124
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services Patient Focused Services Patient-Centric Initiatives

White Paper: Pioneering Patient-Centric Growth: Navigating Success with Journey Maps and Co-Creation

Whitepaper Image

ID: BEB-97


Pages/Slides: 9


Published: 2023


Delivery Format: PDF


 

License Options:


Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
In an era where patients are actively shaping their healthcare journeys, pharmaceutical organizations are racing to embrace patient-centricity. Amid the plethora of patient-focused solutions, the strategic employment of patient journey mapping and co-creation has emerged as a pivotal means for pharma to listen to the patient voice and unlock invaluable insights.

Forward-thinking companies have leveraged patient journey mapping to traverse the labyrinth of a patient's experience, from the emergence of symptoms to diagnosis, treatment, and long-term management. This understanding is further elevated by a paradigm shift towards co-creation, where patients are engaged early – whether it be in the research and development phase, crafting comprehensible lay summaries, devising groundbreaking treatments, or co-creating educational and support resources.

Best Practices, LLC engaged representatives from 26 biopharma manufacturers in a benchmarking study – spotlighted in this white paper – to help biopharma leaders foster patient-centric growth. It delves into innovative approaches, winning practices, and recommended vendors whose contributions have left a profound imprint on patient journey mapping and co-creation. This white paper illuminates the critical aspects of patient journey mapping: capabilities, structure, staffing, high-impact areas, data sources, validation, automation, choice of vendors, innovation, and key performance indicators (KPIs). It further underscores the burgeoning significance of patient co-creation, covering program design phases, engagement channels, high-impact realms, and the latest innovative trends.

The findings and benchmarks examined in this white paper include:

  • Patient Journey Mapping Capabilities, Structure, and Staffing
  • Patient Journey Mapping Sources, Impact, and Validation
  • Patient Journey Mapping Tools, Updates, and Automation
  • KPIs to Measure Patient Journey Mapping Capability
  • Vendors for Innovative Patient Journey Approaches
  • Use of Patient Co-creation Programs
  • Effective Channels for Co-creation
  • Frequency of Co-Creation Insights Utilization
Industries Profiled:
Consulting; Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research; Communications


Companies Profiled:
Pharma; Biotech; Medical Device Companies